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the involvement of molecular coincidence detection mechanisms 
(Bourne and Nicoll, 1995; Konnerth et al., 1996; Tsien, 2000). 
Some prominent examples include: (1) the NMDA subtypes of 
glutamatergic receptors that require both membrane depolari-
zation and glutamate for activation of the receptor-coupled ion 
channel, (2) calcium-sensitive forms of adenylate cyclase that 
require coincident stimulation by G-protein alpha-S subunit 
(Gα
S
) and Ca2+/calmodulin (Anholt, 1994) for full activity, and 
(3) certain protein kinase C (PKC) isoforms that require coin-
cident Ca2+ and diacylglycerol (DAG) binding before PKC can 
phosphorylate its target substrates. The preceding list is only a 
partial one; numerous other molecules have also been implicated 
as coincidence detectors.
Studies of excitatory classical conditioning of the nudibranch 
mollusk Hermissenda crassicornis have provided extensive infor-
mation about the behavioral, circuit-level, cellular, and molecu-
lar changes that occur during associative learning (Crow, 2004; 
Blackwell and Farley, 2008). Several molecular coincidence detec-
tors (e.g., PKC) have been implicated in these changes (Farley and 
Auerbach, 1986; Farley and Schuman, 1991). Hermissenda have also 
been shown to exhibit inhibitory classical conditioning (Britton 
and Farley, 1999). Thus, Hermissenda provides the opportunity 
for detailed studies of inhibitory conditioning and mechanisms 
of non-coincidence detection, as well as explicit comparisons with 
mechanisms involved in excitatory conditioning.
IntroductIon
An important, but poorly understood, issue in the cellular analy-
sis of learning and memory is how the stimulus relationship of 
“non-coincidence” is encoded and represented within the brain. 
Organisms not only learn that stimuli co-occur, as in standard 
forms of excitatory Pavlovian/classical conditioning (Domjan, 
2010). But they also readily learn that certain stimuli do not co-
occur, as in Pavlovian/classical conditioned inhibition learning. If 
the unconditioned stimulus (US) is an aversive one, such as electric 
shock, then the result of pairings (called excitatory conditioning) 
of a conditioned stimulus (CS) and US may be the conditioning 
of fear to that cue (Estes and Skinner, 1941). Alternatively, if a 
different CS reliably predicts the absence of electric shock, the 
learning that results may be “safety signal” learning, or the con-
ditioning of “relief”, a central emotional state that is functionally 
opposite to that of fear. Indeed, a common characterization of 
inhibitory Pavlovian/classical conditioning regards the organism 
as learning that one stimulus (the CS) predicts the absence of 
the other (the US) (Rescorla, 1969; Domjan, 2010), just as the 
organism learns that a CS predicts the presence of a US during 
excitatory conditioning.
A common theme in cellular and molecular accounts of both 
classical and instrumental conditioning processes, where learning 
is critically dependent upon temporal contiguity of CS and US 
or response and consequence (viz., excitatory conditioning), is 
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Previous research on excitatory conditioning in Hermissenda 
has shown that these animals readily learn that light predicts the 
presence of turbulence (vestibular stimulation via high-speed cir-
cular or orbital rotation) when light, the CS, is repeatedly paired 
with high-speed rotation, the US (Crow and Alkon, 1978; Farley 
and Alkon, 1980). The behavioral consequences of this learning are 
decreases in several components of phototactic behavior (Farley 
and Alkon, 1982; Crow and Offenbach, 1983), as well as the elici-
tation of a “clinging” response to light, which is evoked only by 
rotation/turbulence prior to pairings (Lederhendler et al., 1986). 
Primary neural substrates of this form of excitatory conditioning 
involve persistent changes in the neuronal excitability and pho-
toresponses of the ocular Type A and B photoreceptors (Crow and 
Alkon, 1980; Alkon et al., 1982, 1985; Farley, 1987a,b, 1988; Farley 
and Alkon, 1982), with the Type B photoreceptors receiving the 
most attention to date. Excitatory conditioning (light-rotation 
pairings) produces a number of changes in the neurophysiological 
properties of Type B photoreceptors, including increases in depo-
larizing light-induced generator potentials, spike frequencies, and 
resting input resistances (Crow and Alkon, 1980; Farley and Alkon, 
1982; Farley, 1987a, 1988).
Just as pairings of light and rotation result in persistent increases 
in the excitability and light-responses of Type B photoreceptors, 
owing in part to decreases in somatic K+ currents (Alkon et al., 1982; 
Farley, 1988), explicitly-unpaired presentations (EU) of the same 
two stimuli (an inhibitory conditioning paradigm) result in per-
sistent decreases in excitability and light-responses (light-induced 
generator potentials and spike frequencies) of Type B photorecep-
tors (Britton and Farley, 1999).
The question of how inhibitory conditioning, or more gener-
ally “non-coincidence” learning, is represented in the brain can 
be subdivided into: (1) what mechanisms account for expression 
of altered excitability and synaptic transmission due to inhibitory 
conditioning, (2) what mechanisms and signal transduction cas-
cades are involved in the induction of these changes?
The present report is concerned with both issues. Several lines 
of research have focused our attention on arachidonic acid (AA) 
signaling pathways as critical mediators of expression of some of 
the alterations in the neurophysiological responses of Type B pho-
toreceptors that are produced by EU light/rotation presentations 
in Hermissenda. First, in both invertebrate and vertebrate neurons, 
AA signaling has often been linked to increases in voltage- and/
or calcium-dependent K+ currents. In Aplysia mechanosensory 
neurons, AA and 12(S)-HPETE metabolites activate the FRMF-
amide stimulated S-K+ channel, and consequently reduce synap-
tic transmission (Piomelli et al., 1987b; Buttner et al., 1989). AA 
has also been found to increase the activity of large-conductance, 
Ca2+-dependent K+ channels in cardiac (Kim and Clapham, 1989; 
Ordway et al., 1991; Wallert et al., 1991), gastric (Ordway et al., 
1989b), and pulmonary (Ordway et al., 1989a) smooth muscle 
cells. In mammalian neurons, AA enhances M-current (K
v
7.2/3) 
K+ channels in hippocampal pyramidal (Schweitzer et al., 1990, 
1993), sympathetic ganglion (Villarroel, 1994), as well as embry-
onic mesencephalic and hypothalamic neurons (Kim et al., 1995). 
Second, because AA can be metabolized into multiple bioactive 
metabolites, AA-signaling has the potential to produce diverse, 
combinatorial signaling effects. In Aplysia L14 neurons, for exam-
ple, the 12(S)-HPETE metabolite of AA can produce both a rapid 
depolarization as well as a slower hyperpolarization (Piomelli et al., 
1987a, 1989), mimicking the effects of histamine. These opposing 
effects on excitability appear to be mediated by distinct ion chan-
nels. In Hermissenda, AA has been reported to act synergistically 
with diacylglycerol (DAG) and Ca2+ to activate PKC (Lester et al., 
1991), suggesting its involvement in excitatory conditioning (Talk 
et al., 1997; Muzzio et al., 2001). While the exact mechanism for 
the effect of AA on PKC is uncertain, it has been assumed that AA 
binds PKC directly (Lester et al., 1991).
Given the potential pleiotropic and opposing signaling effects 
of AA, its activation of diverse K+ channels in many cell types, and 
EU-produced increases in voltage- and Ca2+-dependent K+ channels 
in Hermissenda (Farley et al., 1999), AA signaling is an attractive 
candidate to mediate some of the inhibitory conditioning induced 
changes in Hermissenda Type B photoreceptors. We have exam-
ined that possibility here by assessing the effects of AA and various 
metabolites on photoresponses, spiking, and other measures of 
membrane excitability of Type B photoreceptors, to see if any of 
these are altered similar to the effects of behavioral EU conditioning. 
We first examined the effects of AA on Type B photoreceptors from 
untrained animals. We observed that AA decreased light-evoked 
spiking in these cells, similar to that produced by EU-conditioning. 
These effects of AA were attributable to lipoxygenase-metabolites; 
12(S)-HPETE appears to be a critical one. We further determined 
that AA-signaling increased the amplitude of the transient, voltage-
dependent A-current in Type B photoreceptors, similar to the effects 
of EU-conditioning (Farley et al., 1999). The A-current is a potent 
regulator of spiking in B photoreceptors, and its increased activa-
tion would be expected to decrease spike frequency. Subsequently, 
we also assessed the effects of AA on the light-evoked spiking of B 
photoreceptors from EU-conditioned animals. When AA was tested 
shortly after the conclusion of behavioral EU-training, we observed 
an apparent occlusion effect: AA failed to decrease spiking similar 
to its effect on B cells from untrained animals. When tested ∼24 h 
following conclusion of EU-training, we observed no occlusion 
effect. But pharmacological inhibition of the 12-lipoxygenase sign-
aling pathway was found to reverse the EU-conditioning produced 
decreases in light-evoked spiking. These observations suggest that 
AA-signaling is one critical mediator of EU-conditioning effects 
in Hermissenda.
MaterIals and Methods
anIMals
Adult Hermissenda were purchased from Sea Life Supply (Sand 
City, CA, USA). All Hermissenda were individually housed in perfo-
rated 50 ml sample tubes and kept in 50 gallon refrigerated (14°C) 
aquaria containing artificial seawater (ASW; Aqua Craft Bio-Sea 
Marinemix). All Hermissenda were subjected to a 12-h light/dark 
cycle and fed scallop pieces twice per week.
BehavIoral traInIng
The procedure and equipment used for behavioral training have 
been previously described (Farley, 1987a; Britton and Farley, 
1999). Animals were selected at random and moved from their 
numbered housing tubes to numbered training tubes containing 
ASW (14°C). The training tubes were then attached to a turntable 
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The procedure used for two-electrode voltage-clamp has been 
described (Jin et al., 2009). The glass microelectrodes (A-M Systems 
#602000) were pulled to ∼15 MΩ when filled with 3 M KCl. After 
impaling a Type B photoreceptor with two electrodes, the nerv-
ous system was dark-adapted. The voltage-clamp protocol was a 
−60 mV holding potential with 400 ms voltage command steps 
from −60 mV to +5 mV in +5 mV steps. The command steps were 
separated by 2 s and a full voltage-clamp trial was administered 
every 5 min. Drugs were applied prior to the third voltage-clamp 
trial and their effect assessed over the remaining voltage trials.
cheMIcals
All drugs, salts, solvents, etc. were reagent grade and all working solu-
tions were prepared from stocks daily and stored at 4°C until used. 
Arachidonic acid (Sigma #A8798), 12(S)-HPETE (Cayman Chemical 
#44570), 5(S)-HPETE (Cayman Chemical #44230), and MK-886 
(Sigma #M2692) were stored at 0.1 M in 100% ethanol at −70°C. 
Baicalein (Sigma #465119) was stored in powder form at 4°C. NDGA 
(nordihydroguaiaretic acid; Cayman Chemical #70300) was stored in 
powder form at -20°C. Daily working solutions of these drugs were 
prepared by diluting the required amount of stock to 10−2 M with 
dH
2
O. The final concentration of ethanol in all experiments never 
exceeded 0.1%. All other chemicals and solvents were stored and 
prepared according to the supplier’s recommendation.
data analysIs
In this paper, we report data for several key measures of Type B pho-
toreceptor light responses and excitability, including: light-evoked 
spike frequency, peak light response, SSGP, resting membrane poten-
tial (V
m
), and R
in
. The left panel of Figure 1E shows a typical response 
to a 30-s light step. Hermissenda Type B photoreceptors respond 
to light with a depolarizing generator potential with superimposed 
spike activity. Within ∼1 s following light onset, the generator poten-
tial reaches a maximal value. The difference between the resting 
membrane potential and this maximal value is defined as the peak 
light response. After a few seconds, the generator potential stabilizes 
(the SSGP) and does not change significantly over the remaining 20+ 
seconds of the light step. The increased spiking elicited by light is 
called the light-evoked spike frequency. Due to the rapidly varying 
changes in generator potential during the first few seconds, we only 
collect spike frequency data during the last 10 s (the stable portion) of 
the light response. R
in
 is described in Section “Electrophysiology.”
Unless stated, summary statistics are arithmetic mean ± SEM. 
The statistical significance of all comparisons reported in this 
paper was assessed using one-way or repeated measures analysis 
of variance (ANOVA) in conjunction with Tukey’s HSD test. For 
all comparisons, two-tailed tests were used and significance was 
only assumed when p < 0.05.
results
aa reduces type B photoreceptor spIke frequency
Explicitly unpaired training decreases several key measures of Type 
B photoreceptor light responses and excitability, including: light-
evoked spike frequency, peak light response, and SSGP (Britton and 
Farley, 1999). If AA signaling mediates any of these EU training related 
changes, then application of AA to nervous systems from untrained 
Hermissenda should mimic some or all of these effects of EU training. 
that was mounted in a refrigerator (∼14°C). Vestibular stimula-
tion was provided by high-speed rotation (100 RPM, ∼2.2 × g) 
on the turntable and ocular stimulation was provided by a light 
(∼300 μW/cm2) mounted above the turntable. Presentation of 
the stimuli was computer controlled. A single trial consisted of 
explicitly unpaired (EU) presentations of light and rotation: 30 s 
of light and 30 s of rotation separated by 4 min (a 9 min inter-trial 
interval; ITI). Animals received 3–6 days of training consisting 
of 30 trials per day. Animals were always trained during the mid-
dle 8 h of light in their 12-h light/dark cycle. At the end of each 
day’s training, the animals were returned to their home tubes 
and aquaria.
electrophysIology
In preparation for electrophysiology, the circumesophageal nervous 
system was removed from an animal and pinned inside a 500-μl well 
comprised of petroleum jelly strips on a microscope slide. Electrode 
impalement was facilitated by incubating the nervous system in a 
non-specific protease solution (1 mg/ml, Sigma #P5380) for ∼9 min 
at room temperature. To remove the protease, the nervous system 
was thoroughly washed with cold (∼4°C) ASW. The well containing 
the nervous system was then filled with 500 μl of room temperature 
ASW (430 mM Na+, 10 mM K+, 10 mM Ca2+, 50 mM Mg2+, 10 mM 
Tris HCl, and 570 mM Cl−, pH = 7.6–7.8). For voltage-clamp experi-
ments, all photoreceptor synaptic interactions and spike generation 
were eliminated via axotomy (Alkon and Fuortes, 1972).
The procedure used for sharp-electrode intracellular recording 
has been described (Farley, 1987a,b). Glass microelectrodes (A-M 
Systems #602000) were pulled to a tip resistance of ∼ 40 MΩ when 
filled with 1.5 M potassium acetate. After impaling a Type B pho-
toreceptor and checking the initial light response to a brief flash of 
light, the cell was dark-adapted for 10 min. During the final 1–2 min 
of dark-adaptation, the resting input resistance (R
in
) of the B pho-
toreceptor was measured by using 500 ms current step injections 
(−0.5 nA to +0.1 nA in 0.1 nA increments). At the end of the 10-min 
dark-adaptation period, light stimulation began: 30 s presentations 
of light (∼300 μW/cm2) were delivered at 2 min inter-stimulus 
intervals (ISIs) until a total of 15 consecutive light steps had been 
presented. When drugs were applied acutely, they were added dur-
ing the 4th light step. As described below, when inhibitors of AA 
signaling pathways were used, they were added 20–30 min prior to 
the start of electrophysiological recording. With the present light 
stimulation protocol, Type B photoreceptors reached a steady-state 
level of light-adaptation after 3–4 light steps, exhibiting constant 
peak- and steady-state generator potentials (SSGP), as well as spike 
frequencies (changes <5% over the course of the next 11–12 light 
steps). Following the 15 light steps, the cell was then dark-adapted 
again for 10 min, and R
in 
was re-measured. Because the final R
in
 
check occurred at least 40 min after impalement, the recording 
electrode would occasionally block, leading to erroneous R
in
 meas-
urements. R
in 
data from these cells were discarded. As mentioned 
above, drugs (except inhibitors) were applied during the fourth 
presentation of light and their effects assessed over the remaining 
light presentations. Because many inhibitors require time to diffuse 
and penetrate cell membranes within the ganglia and their con-
centration to reach equilibrium, nervous systems were incubated 
in the inhibitors for 20–30 min prior to recording.
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9–12 months. The principal results for the two separate replica-
tions were extremely similar (Figures 1B,C). For the first replica-
tion, AA reduced light-evoked spike frequency by 20.1 ± 11.4% 
(n = 4), while vehicle slightly decreased spiking by 2.6 ± 1.1 (n = 8) 
[F(1,10) = 5.47, p < 0.05]. For the second replication, conducted 
9–12 months later (when the results of Figures 3–6 were collected), 
AA decreased light-evoked spiking 20.1 ± 4.8% (n = 6), while vehicle 
slightly decreased spiking by 0.9 ± 4.8% (n = 6) [F(1,10) = 5.01, 
p < 0.05]. Because there was no significant difference between the 
To test this, we applied AA (10−4 M) to nervous systems from untrained 
Hermissenda and found that AA reduced light-evoked spike frequency 
in Type B photoreceptors an average of 20.1 ± 5.1% (n = 10), while 
vehicle (dH
2
O in 0.1% ethanol) alone slightly decreased spiking by 
1.9 ± 2.0% (n = 14). The difference in response of B cells to AA vs. 
vehicle was significant [F(1,22) = 11.09, p < 0.01] (Figure 1A).
The preceding data represent the pooled results from two 
separate and independent replications using different shipments 
of animals, different lots of AA, etc, separated by a period of 
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FigurE 1 | Arachidonic acid mimics the reduction in spike frequency 
observed following Eu training. (A through C) Applied after the 3rd light step, 
AA (10−4 M) reduced light-evoked spiking over the remaining 12 light steps 
(∼22–24 min). In contrast, the spike frequency of Type B photoreceptors 
exposed to vehicle (dH2O + 0.1% ethanol) was essentially unchanged over the 
same period. Changes in spike frequency are expressed as percent change 
relative to that observed during the third light step, just prior to AA or vehicle 
addition. (A) Shows pooled data from two independent replications (shown in 
B and C). (D) The reduction in spike frequency produced by AA mimicked the 
reduction produced by EU training. During the 15th light step, Type B 
photoreceptors from untrained Hermissenda spiked at 7.2 Hz; however, when 
treated with AA, Type B photoreceptors from untrained Hermissenda spiked at 
5.4 Hz. In comparison, after EU training, Type B photoreceptors spiked at 5.4 Hz. 
In A through D, as well as in all subsequent figures for which summary data are 
presented, each data point represents a mean ± SEM. (E) Representative light 
response from a Type B photoreceptor treated with AA: 3rd light step (left) and 
15th light step (right). Note the reduction in spike frequency, which was 41% for 
this cell (during the last 10 s of the light response).
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show spontaneous spikes before and/or after AA. The AA-exposed 
Type B cells included in this analysis showed no significant dif-
ferences in spontaneous spike frequency (in the dark) during the 
time periods just prior to the 4th and 15th LS, when compared to 
vehicle-exposed cells. In addition, the reduction in spike frequency 
from the 4th to the 15th LS was comparable for AA- vs. vehicle-
exposed cells: a 39.4 ± 23.2% reduction for AA (n = 7) compared 
to a 18.6 ± 22.5% reduction for vehicle (n = 5); p = 0.55, t-test. 
These same Type B cells showed no appreciable changes in spike 
amplitude (an increase of 0.6 ± 0.3 mV; p = 0.32), nor changes 
in the amplitude of the spike after-hyperpolarization (AHP) (in 
increase of 0.5 ± 0.7 mV; p = 0.52, t-test), for spikes measured dur-
ing the time periods just prior to the 4th and 15th LS. However, 
there was a trend for spike duration to be shorter following AA 
addition, with five of seven cells showing a reduction of 20% or 
more. For all seven cells, spike duration was 9.63 ± 0.6 ms prior 
to the 4th LS; after AA (just before the 15th LS) spike duration 
was 8.28 ± 0.8. Although suggestive, and consistent with AA hav-
ing enhanced a component of voltage-dependent K+ current (see 
below) involved in spike re-polarization, this difference was non-
significant (p = 0.22, t-test).
effects of lIpoxygenase and cyclooxygenase InhIBItors
Arachidonic acid may affect ion channels or enzymes via direct 
binding. AA may also be metabolized by lipoxygenase or cycloox-
ygenase enzymes to produce active signaling molecules, like 
hydroperoxy-eicosatetraenoic acids (HPETEs) or leukotrienes. 
Many of these metabolites modulate various ion channels or 
bind to diverse intra- or extracellular receptors. To determine 
if metabolites of AA contribute to the effect of AA on Type B 
photoreceptor spike frequency, we applied AA in the presence of 
NDGA, a non-specific lipoxygenase inhibitor, and indomethacin, 
a non-specific cyclooxygenase inhibitor [significant main effect: 
F(2,18) = 4.015, p < 0.05] (Figure 2A). NDGA (10−4 M; n = 5) 
blocked the effect of AA (p < 0.05, Tukey’s HSD) without causing 
any conspicuous effect of its own on light-evoked spike frequency 
[7.3 ± 0.2 Hz vs. 7.3 ± 0.3 Hz for vehicle only; F(1,15) = 0.19, 
p = 0.67], SSGP [16.3 ± 0.9 mV vs. 20.7 ± 2.2 mV for vehicle only; 
F(1,13) = 1.39, p = 0.26], or V
m
 [−48.8 ± 1.7 mV vs. −49.3 ± 3.7 mV 
for vehicle only; F(1,13) = 0.01, p = 0.93]. This suggests that one 
or more lipoxygenase metabolites rather than AA itself mediated 
the reduction in Type B photoreceptor spike frequency. In con-
trast to NDGA, indomethacin (10−4 M; n = 4) had pronounced 
effects on the Type B photoreceptor light-response. Although 
the AA-produced reduction in light-evoked spike frequency was 
attenuated somewhat in the presence of indomethacin (a decrease 
of 10.7 ± 2.6% compared to the 20.1% decrease produced by 
AA alone [p = 0.194; Tukey’s HSD]), prior to AA application, 
Type B photoreceptors exposed to indomethacin exhibited SSGPs 
that were considerably larger (28 ± 2.9 mV vs. 18.2 ± 1.8 mV for 
vehicle only; F(1,14) = 10.64, p < 0.01) than those of Type B 
photoreceptors not exposed to indomethacin (Figure 2B). While 
indomethacin appeared to attenuate the reduction in spike fre-
quency produced by AA, that attenuation may have been due to 
the increased light-response caused by indomethacin. Based on 
this data, we cannot exclude a contribution from cyclooxygenase 
metabolites, but the NDGA results and the results of the next 
two replications, for either AA or controls, we combined the results 
of the two replications for added statistical power (Figure 1A). This 
pooled vehicle and AA data is used in all remaining comparisons 
and figures. We also note that the results of these two replications 
were very similar to our preliminary AA results collected years 
earlier by different experimenters using a different solvent (DMSO), 
chemicals/supplies, animals, data collection protocol, and equip-
ment etc (Farley et al., 2003). In that study, AA-exposed (10−4 M) B 
cells (n = 7) showed a decrease of 17% after ∼8–10 min. The DMSO 
(0.1%) solvent-alone control cells (n = 4) showed no change in spike 
frequency. As in the present replications, neither AA nor solvent 
control had any effect on SSGP, V
m
, or R
in
. Thus, the effects of AA 
appear to be quite reliable. Figure 1E shows a representative trace 
of the effect of AA on a single Type B photoreceptor: before AA (3rd 
light step; left panel) and after AA (15th light step; right panel).
Because the reduction in spike frequency produced by AA qualita-
tively mimicked the reduced spike frequencies produced by EU train-
ing in previous studies (Britton and Farley, 1999; Farley et al., 1999), 
we also directly compared the effects of AA on cells from untrained 
animals with the effects of behavioral EU conditioning in the present 
study (Figure 1D). As described in Section “Behavioral training” 
and in additional detail below, a group of animals was exposed to 
multi-day EU training. AA stimulation of untrained cells and EU 
conditioning produced quantitatively similar reductions in spike 
frequency (Figure 1D). During the 15th light step, Type B photore-
ceptors from untrained Hermissenda treated with vehicle spiked at 
7.2 ± 0.4 Hz (n = 14). When treated with AA, Type B photoreceptors 
from untrained Hermissenda spiked at 5.4 ± 0.6 Hz (n = 10) during 
the 15th light step. In comparison, 24-h after EU training (described 
in Section “Behavioral training”), Type B photoreceptors treated 
with vehicle spiked at 5.4 ± 0.5 Hz (n = 9) during the 15th light 
step. In Figure 1D, the mean spike frequencies for the vehicle- and 
AA-untrained conditions were taken from the pooled AA and vehicle 
data discussed in the previous paragraph. The mean spike frequency 
for the vehicle-EU condition was taken from the data presented in 
Figure 6 and discussed in Section “Involvement of AA in inhibitory 
conditioning.” As discussed in the previous paragraph, collection of 
the vehicle-EU data and the second replication of the vehicle- and 
AA-untrained data overlapped. For added statistical power, we com-
pared the vehicle-EU data with the pooled vehicle- and AA-untrained 
data. There was a significant difference between these three conditions 
[F(2,32) = 4.47, p < 0.05]. The difference between the spike frequency 
of Type B photoreceptors from untrained Hermissenda that did not 
receive AA and the spike frequencies of the other two conditions was 
statistically different (p < 0.05 respectively; Tukey’s HSD). But the dif-
ference between cells from untrained Hermissenda that received AA, 
and cells from Hermissenda that received EU training only (no AA) 
was not different (p = 0.88; Tukey’s HSD). In summary, application of 
AA to Type B photoreceptors from untrained Hermissenda mimicked 
the effect of EU training on light-evoked spiking. While AA produced 
a moderate but clear and highly reliable decrease in spike frequency, 
AA had no significant effect on SSGP [an increase of 0.8 ± 0.7 mV; 
F(1,19) = 0.21, p = 0.65], or V
m
 [a depolarization of 1.1 ± 1.9 mV; 
F(1,19) = 0.05, p = 0.83].
We also examined the effects of AA on the characteristics of 
spontaneously occurring spikes. In this analysis, only a subset of 
cells (7 of 10) exposed to AA was used because the others failed to 
Frontiers in Behavioral Neuroscience www.frontiersin.org August 2010 | Volume 4 | Article 50 | 6
Walker et al. 12-Lipoxygenase signaling and inhibitory learning
In contrast, the effect of 12(S)-HPETE on spiking was delayed by 
many minutes. It is tempting to speculate that the different time-
courses may reflect differential penetration of AA vs. 12(S)-HPETE 
into B cells. The pK
a
 value of AA is ∼7, while the PK
a
 value of 12(S)-
HPETE is greater than 7 due to the peroxide group. Thus, the effect 
of 12(S)-HPETE may take longer to develop because 12(S)-HPETE 
would be expected to take more time to cross the Type B photore-
ceptor membrane (i.e., become protonated). Without additional 
research, we cannot say if the delayed response of 12(S)-HPETE 
represents a physiologically significant difference or is a conse-
quence of pharmacokinetics.
Many enzymes may metabolize AA and more than one of these 
enzymes may be expressed in a given cell. Furthermore, if multiple 
enzymes are expressed, their effects could be cooperative, synergistic, 
or antagonistic. Because 5-lipoxygenase enzymes also metabolize 
AA and are another significant member of the lipoxygenase family 
of enzymes, we examined the potential contribution of this enzyme 
to AA’s effect on Type B photoreceptor spike frequency. Thus, we 
tested the ability of MK-886 (10−4 M), a reportedly selective inhibi-
tor of 5-lipoxygenase activity, to block the effects of AA. We also 
tested the ability of 5(S)-HPETE (10−4 M), the metabolite produced 
by 5-lipoxygenase activity, to mimic the effect of AA (Figure 3B). 
Clear differences between the treatment conditions in Figure 3B 
were apparent: significant main effect of treatment, F(3,33) = 8.09, 
p < 0.01. When nervous systems from untrained Hermissenda were 
incubated in MK-886, AA failed to reduce the light-evoked spike 
frequency in Type B photoreceptors (a small increase of 1.9 ± 2.9% 
was observed, n = 7). The response to AA of MK-886 treated cells 
was significantly different from that of cells exposed to AA alone 
(p < 0.05, Tukey’s HSD), but not different from that of cells exposed to 
vehicle alone (p = 0.98, Tukey’s HSD). In contrast, 5(S)-HPETE failed 
to reduce light-evoked spike frequency (an increase of 4.3 ± 6.1%, 
n = 6) and thus was significantly different from AA alone (p < 0.01, 
Tukey’s HSD) but not vehicle (p = 0.26, Tukey’s HSD). There are sev-
eral possible explanations for this inconsistency between the effects 
of the 5-lipoxygenase inhibitor (MK-886) and metabolite [5(S)-
HPETE]. One possibility is that MK-886 acts directly on ion channels 
affected by AA or its metabolites. For example, MK-886 reportedly 
competes with AA or 12(S)-HPETE for a K+ channel  binding site 
section suggests that a lipoxygenase metabolite contributes the 
majority of AA’s effect on light-evoked spike frequency in Type 
B photoreceptors.
effects of aa are MedIated By a 12-lIpoxygenase MetaBolIte
Because the NDGA results (Figure 2A) suggest that AA’s effects are 
mediated by a lipoxygenase metabolite, we turned our attention to 
the lipoxygenase family of enzymes. Because presynaptic inhibition 
of synaptic transmission and opening of a K+ channel in Aplysia 
appear to be mediated by a metabolite of a 12-lipoxygenase enzyme 
(Piomelli et al., 1987b; Buttner et al., 1989), we next tested the ability 
of baicalein, a selective 12-lipoxygenase inhibitor, to block the effects 
of AA. We also tested the ability of 12(S)-HPETE, the metabolite 
produced by 12-lipoxygenase activity on AA, to mimic the effects 
of AA (Figure 3A). Clear differences between the treatment condi-
tions in Figure 3A were apparent, consistent with AA’s effects being 
mediated by a 12-lipoxygenase metabolite: significant main effect 
of treatment F(3,32) = 4.85, p < 0.01. When Type B photoreceptors 
from untrained Hermissenda were incubated in baicalein (10−4 M; 
n = 7), baicalein blocked the effect of AA on Type B photoreceptor 
spiking (p < 0.05, Tukey’s HSD). When 12(S)-HPETE (10−4 M) was 
applied to nervous systems from untrained Hermissenda, 12(S)-
HPETE reduced light-evoked spike frequency 24.4 ± 9.2% (n = 5; 
p < 0.05, Tukey’s HSD), mimicking the effect of AA on spiking (a 
reduction of 20.1%). Note: the comparisons in Figures 3A–C make 
use of pooled data for the vehicle and AA conditions. As discussed 
in Section “AA Reduces Type B Photoreceptor Spike Frequency,” 
we collected vehicle and AA data twice during this study. Data for 
the first replication were collected early in the study while data for 
the second replication were collected in conjunction with the other 
data shown in Figures 3A–C. As discussed in Section “AA Reduces 
Type B Photoreceptor Spike Frequency,” there was no difference 
between the two vehicle replications and there was no difference 
between the two AA replications. As a result, we pooled the data 
for the vehicle and AA conditions to increase the statistical power 
of all comparisons.
Interestingly, while the effects of AA and 12(S)-HPETE on spik-
ing were nearly identical at the 15th light step, their time-courses 
were different. AA produced a slow, continuous decrease in spiking. 
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FigurE 2 | NDgA blocks the reduction in light-evoked spike frequency 
produced by AA. (A) The light-evoked spike frequency reduction produced by 
AA appears to be blocked by NDGA and indomethacin. (B) Representative light 
responses from a control Type B photoreceptor exposed to vehicle (left) and 
another cell exposed to indomethacin (right), both in the absence of AA. Note 
the enhanced light-response of the indomethacin treated cell. This enhanced 
light-response may account for the apparent attenuation of AA’s effect on 
light-evoked spike frequency.
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effects of aa on k+ currents
Voltage clamp measurements indicated that AA-exposure (10−4 M) 
increased both the transient (I
A
) and sustained components of 
somatic voltage-dependent K+ current in Type B photoreceptors 
(n = 4) (Figure 4). On average, I
A
 was increased by ∼18–44%, 
depending upon the test potential. Tests of I
A
 values over the range of 
−30 to +5 mV, 12–15 min following AA-exposure, indicated that the 
currents were significantly increased [main effect of AA-exposure: 
F(1,2) = 17.93, p = 0.05]. The interaction between AA-exposure 
and test voltage was also significant, indicating that AA’s facilitation 
of I
A
 increased with depolarization [F(7,14) = 12.54, p = 0.0005] 
(Figure 4B).
Further analysis indicated a trend for AA to have enhanced the 
sustained component of K+ current (I
Delayed
), measured at the end 
of the 400 ms clamp step (Figure 4C). On average, the effect of AA 
on I
Delayed
 was weaker and less reliable than the facilitation of peak 
A current. Test of the main effect of AA indicated that it was non-
significant [main effect of AA-exposure: F(1,2) = 14.80, p > 0.06]. 
However, the interaction between AA-exposure and test voltage was 
significant, indicating that AA facilitation of I
Delayed
 was dependent 
upon the test potential [F(7,14) = 7.51, p = 0.001] (Figure 4C).
I
Delayed 
is a composite current, consisting of residual I
A
, non-
 inactivating I
K,v
, and I
K(Ca)
 (Alkon et al., 1984; Farley, 1988; Farley 
and Wu, 1989; Jin et al., 2009). On the basis of our present findings, 
(Smirnov et al., 1998). If this were happening in Hermissenda Type 
B  photoreceptors, it would suggest that MK-886’s block of AA’s effect 
might be because MK-886 interferes with 12(S)-HPETE’s activation 
of a K+ channel (e.g., I
A
 channels, see below) rather than because of its 
inhibition of 5-lipoxygenase activity. To test this, we applied MK-886 
prior to 12(S)-HPETE (n = 3) (Figure 3C), and observed significant 
differences in the response to 12(S)-HPETE depending upon whether 
cells had been treated with MK-886 or not: significant main effect of 
treatment: F(2,19) = 5.02, p < 0.05. We found that MK-886 blocked 
(p < 0.05, Tukey’s HSD) the effect of 12(S)-HPETE on light-evoked 
spike frequency. Thus, the inconsistency implied by MK-886’s block 
of AA’s effect and 5(S)-HPETE’s failure to mimic AA’s effect seems to 
arise from an effect of MK-886 that is independent of its inhibition 
of 5-lipoxygenase. MK-886 may block the activation of a K+ chan-
nel by 12(S)-HPETE, and/or interact with other components of the 
12-lipoxygenase signaling pathway.
In summary, the consistent results obtained for baicalein (a 
12-lipoxygenase inhibitor) and 12(S)-HPETE imply that a 12-lipox-
ygenase metabolite is critical for mediating AA’s reduction of Type 
B photoreceptors light-evoked spike frequency. The inconsistent 
results obtained for MK-886 (a 5-lipoxygenase inhibitor) and 5(S)-
HPETE prevent us from inferring that a 5-lipoxygenase metabolite 
contributes to the effect of AA. However, we cannot exclude a pos-
sible role for 5-lipoxygenase at present.
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FigurE 3 | The effects of AA are mediated by a 12-lipoxygenase metabolite. 
(A) Baicalein (10−4 M, n = 7), a selective 12-lipoxygenase inhibitor, blocked the 
reduction in light-evoked spike frequency produced by AA. 12(S)-HPETE (10−4 M, 
n = 5) mimicked the effects of AA on light-evoked spike frequency. (B) MK-886 
(10−4 M, n = 7), a reportedly selective inhibitor of 5-lipoxygenase activity, also 
blocked the effect of AA. However, 5(S)-HPETE (10−4 M, n = 6) failed to mimic 
the effect of AA. (C) MK-886 also blocked the effect of 12(S)-HPETE, suggesting 
that its actions are not restricted to inhibition of 5-lipoxygenase activity. 
(A–C) Use the pooled data depicted in Figure 1A; see Section “AA Reduces 
Type B Photoreceptor Spike Frequency” for a detailed description.
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application, the spike frequency of these cells had returned to base-
line and there was no difference between them and Type B photore-
ceptors from EU0 Hermissenda exposed to vehicle (dH
2
O + 0.1% 
ethanol, n = 6) [F(1,16) = 0.743, p = 0.401] (Figure 5A). As was 
the case for Type B photoreceptors from untrained Hermissenda, 
AA did not produce a significant change in SSGP [an increase of 
0.5 ± 1.3 mV; F(1,19) = 0.21, p = 0.65] or V
m
 [a depolarization of 
1.7 ± 3.0 mV; F(1,19) = 0.12, p = 0.74]. During the 3rd light step, the 
spike frequency of Type B photoreceptors from EU0 Hermissenda 
was 6.4 ± 2.4 Hz. In contrast, the light-evoked spike frequency 
for Type B photoreceptors from untrained and EU24 Hermissenda 
were 7.0 ± 0.4 Hz and 4.9 ± 0.4 Hz, respectively (Figure 5B) 
[F(2,68) = 8.458, p < 0.01]. Due to the large variability between 
EU0 experiments, the spike frequency for B cells from EU0 animals 
was not significantly different from that of untrained Hermissenda 
(p = 0.22, Tukey’s HSD). That is, unlike EU24 Hermissenda, there 
was no clear reduction in light-evoked spiking for B cells immedi-
ately after training (EU0 Hermissenda).
For Type B photoreceptors from EU24 Hermissenda, we observed 
that light-evoked spike frequencies during the 3rd light step (prior 
to AA application) were significantly smaller than that of untrained 
preparations (4.9 ± 0.4 Hz, n = 9 vs. 7.0 ± 0.4 Hz, n = 15) (p < 0.01, 
Tukey’s HSD) (Figure 5B), which replicates our previous findings 
(Britton and Farley, 1999). We also tested the effects of AA and 
we cannot be more precise as to which component(s) of I
Delayed
 may 
have been affected by AA. It is possible that the small increases in 
I
Delayed
 reflect the effects of AA on residual I
A
.
InvolveMent of aa In InhIBItory condItIonIng
If AA or one of its metabolites [e.g., 12(S)-HPETE] mediates the 
reduction in light-evoked spike frequency produced by EU train-
ing, then we would expect a change in sensitivity to exogenous 
AA in Type B photoreceptors from Hermissenda that have been 
subjected to EU training. For example, EU training might occlude 
the reduction in spike frequency produced by exogenous AA. 
Alternatively, EU training may cause up- (or down-)regulation of 
enzymes involved in AA metabolism and therefore an increased 
(or decreased) response to exogenous AA, i.e., a further decrease 
in spike frequency. Because there are other possible EU training-
related changes that may affect AA sensitivity, additional more com-
plex changes in response to exogenous AA would not be entirely 
unexpected. To explore these issues, we examined the effects of AA 
on Type B photoreceptors at two different retention intervals, fol-
lowing the conclusion of standard EU training: immediately after 
(EU0), or 24 h after (EU24), the last training session.
For Type B photoreceptors from EU0 Hermissenda, we found that 
AA (10−4 M, n = 15) produced a small but reliable transient increase 
in light-evoked spike frequency. However, ∼25–30 min after AA 
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FigurE 4 | Arachidonic acid (10−4 M) increases K+ currents of Type B 
photoreceptors. (A) Left traces: Examples of currents elicited by depolarization 
of a voltage-clamped type B photoreceptor, just prior to AA exposure. Right 
traces: Currents from same cell recorded at same test potentials, 15 min 
following exposure to AA. Current traces depicted were elicited by 
depolarizations from −15 to +5 mV, in 5 mV increments. Both the transient and 
sustained components of K+ current were increased. (B,C) Summary 
current–voltage relationships for IA (B) and IDelayed (C), before and after (∼15 min) 
exposure of cells (n = 4) to AA. AA enhanced both IA and IDelayed, though the effect 
was greater and more reliable in the case of IA.
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Tukey’s HSD), suggesting that a 12-lipoxygenase metabolite was 
responsible for the reduced spiking of Type B photoreceptors from 
EU24 Hermissenda. Neither baicalein (7.3 ± 0.5 Hz, n = 7; p = 1.00, 
Tukey’s HSD) nor MK-886 (7.2 ± 0.3 Hz, n = 7; p = 1.00, Tukey’s 
HSD) affected the baseline spike frequencies of Type B photorecep-
tors from untrained Hermissenda (7.0 ± 0.4 Hz, n = 15).
In summary, EU training apparently occluded the effects of AA 
when the latter was tested shortly after training (EU0 condition), 
suggesting that AA-metabolites are contributing to the training-
produced differences in neurophysiological responses of Type B 
photoreceptors at this time, or training has inhibited 12-lipox-
ygenase activity. Twenty-four hours after EU training, however, 
AA reduced spike frequency by approximately the same amount 
as it did in untrained animals, and the 12-lipoxygenase inhibi-
tor baicalein blocked this effect. One interpretation of this pat-
tern is that AA signaling is not contributing differentially to Type 
B photoreceptor light-evoked spike frequencies of untrained vs. 
AA+ baicalein on Type B photoreceptors from EU24 Hermissenda 
(Figure 6A) [significant main effect: F(2,19) = 3.60, p < 0.05]. We 
found that AA (10−4 M) reduced the light-evoked spike frequency 
by 21.9 ± 10.5% (n = 9; p < 0.05, Tukey’s HSD) in B cells from EU24 
animals, and further that the effect of AA on light-evoked spike 
frequency was blocked by prior incubation of nervous systems in 
baicalein (10−4 M; n = 6, p < 0.05, Tukey’s HSD). As was the case 
in the previous experiments in this report (Figure 1C), AA pro-
duced no significant effect on SSGP [an increase of 0.3 ± 1.2 mV; 
F(1,17) = 0.06, p = 0.82] or V
m
 [a depolarization of 2.9 ± 2.3 mV; 
F(1,17) = 0.88, p = 0.36].
Incubation of nervous systems from EU24 Hermissenda in 
baicalein also exposed a significant EU training-induced change 
in 12-lipoxygenase signaling (Figure 6B) [significant main effect: 
F(4,39) = 4.05, p < 0.01]. The reduced baseline (3rd light step) level 
of light-evoked spiking produced by EU training (4.9 ± 0.4 Hz, 
n = 9) was reversed by baicalein (6.9 ± 0.1 Hz, n = 6; p < 0.05, 
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an occlusion effect by EU conditioning. (B) The mean light-evoked spike frequency 
in B cells from EU0 Hermissenda fell between that of untrained and EU24 
Hermissenda; however, it was not significantly different from either one.
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FigurE 6 | Arachidonic acid reduces spike frequency of B cells from Eu 
trained animals, when tested 24 h post-conditioning (Eu24 condition). The 
EU training related reduction in Type B photoreceptor light-evoked spike 
frequency is mediated by 12-lipoxygenase signaling. (A) AA reduced light-
evoked spike frequency in Type B photoreceptors from EU24 Hermissenda. This 
reduction was blocked by incubation in baicalein. (B) Left half. For Type B 
photoreceptors from untrained Hermissenda, MK-886 and baicalein did not 
affect light-evoked spike frequency during the 3rd light step. Right half. For Type 
B photoreceptors from EU24 Hermissenda, light-evoked spike frequency during 
the 3rd light step was significantly reduced, relative to that observed in 
untrained preparations. Baicalein reversed the EU training-related reduction in 
light-evoked spike frequency.
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Arachidonic acid can affect ion channels and receptors through 
both direct as well as indirect means (Ordway et al., 1991; Meves, 
1994). Among the more important indirect mechanisms are: (1) 
AA’s stimulation of protein kinases and phosphatases (Shearman 
et al., 1989; Golberg and Zidovetzki, 1998), (2) AA acting as a 
substrate for enzymatic modification by lipoxygenases, cyclooxy-
genases, cytochrome P450 enzymes etc (Samuelsson et al., 1987; 
Marks and Furstenberger, 1999). The latter class of mechanisms 
has been found to be especially critical for AA’s increase in K+ chan-
nel activity, and decreases in the strength of synaptic transmission 
(Northover, 1977; Piomelli et al., 1987b; Schwartz, 1991; Amin 
et al., 1999; Tegeder et al., 2001). Thus, we attempted to narrow 
the class of mechanisms by which AA affected spiking in Type B 
cells by testing AA’s effects in the presence of lipoxygenase and 
cyclooxygenase inhibitors.
Three sets of observations indicate that AA’s reduction of spik-
ing in B cells is mediated by a lipoxygenase metabolite, probably 
12(S)-HPETE. First, in addition to the block of AA’s effects by the 
non-specific lipoxygenase inhibitor NDGA, we also found that bai-
calein (a specific inhibitor of 12-lipoxygenase) blocked the effects 
of AA on spiking. Second, 12(S)-HPETE, the principal metabolite 
of 12-lipoxygenase, mimicked the effect of AA on B cell spiking. 
Third, while MK-886 (the 5-lipoxygenase inhibitor) appeared to 
block the effects of AA, 5(S)-HPETE failed to mimic AA and MK-886 
blocked the effects of 12(S)-HPETE. None of the lipoxygenase inhib-
itors tested had any effects of their own on SSGP, V
m
 etc in B cells 
from untrained animals. Taken together, our results implicate the 
12-lipoxygenase pathway as a critical mediator of AA’s effects. This 
conclusion obviously does not exclude the possible involvement of 
other lipoxygenases (e.g., the 8- and 15-lipoxygenases) and metabo-
lites [15(S)-HPETE, 8(R)-HPETE, hepoxillins, other leukotrienes 
etc] that we have not yet examined. Lipoxygenase signaling path-
ways are notoriously complex, and many of the key enzymes exhibit 
only partial specificity insofar as their substrates and products are 
concerned (Marks and Furstenberger, 1999). There is ample oppor-
tunity and precedent for cross-talk between the different branches 
of lipoxygenase signaling, as occurs in platelet aggregation.
Indomethacin also partially attenuated (by ∼52%) the reduc-
tion of spiking by AA. This might suggest that some of AA’s effects 
were mediated by a cyclooxygenase (COX) metabolite. However, 
as noted earlier, indomethacin had such pronounced effects on 
SSGP, and other components of the photoresponse and excitabil-
ity that we do not believe its partial abrogation of AA’s effects on 
spike frequency can be unambiguously attributed to inhibition 
of the generation of a COX metabolite. Indomethacin, as well as 
many other non-steroidal anti-inflammatory drugs (NSAIDs), has 
a variety of additional effects that are independent of its inhibition 
of COX activity (Northover, 1977; Singh et al., 1997; Amin et al., 
1999; Tegeder et al., 2001). Some NSAIDs at high concentrations 
have also been reported to inhibit lipoxygenase activity, raising the 
possibility that indomethacin’s partial reduction of AA’s effect on 
spiking was due to inhibition of 12-lipoxygenase. While we cannot 
at present exclude a role for COX metabolites as playing a role in 
AA’s effects, we do not believe that the indomethacin results provide 
strong support for that possibility. Additional studies using COX 
metabolites such as prostaglandins and thromboxanes may help 
to clarify this issue.
EU24 animals, and therefore is not responsible for the expression 
of maintained excitability reductions and spiking differences pro-
duced by EU training. However, the effects of baicalein-alone on 
light-evoked spike frequencies suggests otherwise. When applied 
to Type B photoreceptors from untrained animals, baicalein-alone 
had no effect on light-evoked spiking, suggesting that there is little 
constitutive 12-lipoxygenase activity in Type B photoreceptors from 
untrained animals. When applied to Type B photoreceptors from 
Hermissenda that had undergone EU training and were tested 24 h 
post-conditioning, however, baicalein-alone reversed the decrease 
in baseline light-evoked spiking produced by prior EU training. 
These results suggest that significant constitutive AA-metabolism 
and 12-lipoxygenase activity is occurring 24 h after EU training, such 
that the concentrations of 12-lipoxygenase metabolites [e.g., 12(S)-
HPETE] are elevated, and contribute to the maintained decreases 
in light-evoked spiking. Thus, AA-signaling and 12-lipoxygenase 
metabolites may be contributing to the effects of EU-training on 
neurophysiological responses of Type B photoreceptors at both 
short- and long-term retention intervals, but in different ways.
Finally, comparison of the SSGP between the untrained, EU0, 
and EU24 conditions revealed another significant difference. 
The SSGP for B cells from untrained animals was 18.8 ± 1.3 mV 
(n = 10), while the SSGP for B cells from EU0 and EU24 animals 
were 13.4 ± 0.7 mV (n = 12) and 12.9 ± 0.7 mV (n = 9) respectively 
[significant main effect: F(2,30) = 11.49, p < 0.01]. The SSGP of 
B cells from untrained animals was significantly larger than that 
of B cells from the EU0 and EU24 conditions (p < 0.01 for both 
comparisons, Tukey’s HSD), but the difference between the EU0 
and EU24 conditions was not significant (p = 0.92, Tukey’s HSD). 
The significantly smaller light response of B cells from EU24 ani-
mals (vs. Untrained) replicates our previous results (Britton and 
Farley, 1999). Interestingly, this same difference was apparent in 
cells from EU0 animals, despite the fact that these cells failed to 
show reduced spike frequencies. Interestingly, the large variability 
seen in light-evoked spiking in the EU0 condition was not observed 
in SSGPs. This pattern provides additional evidence for dissociation 
between the expression of EU-training effects on spike frequencies 
vs. photoresponse amplitude, as a function of retention interval, 
and may have its basis in the differential involvement of AA and 
lipoxygenase signaling pathways at these times.
dIscussIon
aa and a 12-lIpoxygenase MetaBolIte reduced spIke frequency 
In type B photoreceptors, sIMIlar to the effects of eu 
condItIonIng
We observed that application of AA to Type B photoreceptors of 
untrained Hermissenda resulted in a ∼20% reduction in spiking 
during the SSGP photoresponse. This reduction was nearly identi-
cal to the magnitude of that produced by behavioral EU training 
(Britton and Farley, 1999). However, unlike behavioral EU training 
which also produces a 7–8 mV reduction in the SSGP photore-
sponse and modest reductions in R
in
 and V
m
 of B cells (Britton and 
Farley, 1999; Farley et al., 1999), AA failed to produce any detectable 
change in SSGP, or V
m
. As discussed in greater detail ahead, this 
failure of AA to completely mimic the effects of EU conditioning is 
likely to be due to behavioral training’s stimulation of several signal 
transduction cascades in B cells, with AA being but one of these.
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Although the strategy of applying an inhibitor (e.g., baicalein) prior to 
and throughout EU-conditioning to see if it blocks the EU-reduction 
of spiking is straightforward in principle, technical difficulties have so 
far prevented us from attempting these experiments. These difficulties 
center on: (1) confining the actions of lipoxygenase inhibitors to Type 
B photoreceptors, when the inhibitor is applied to nervous systems 
of intact or semi-intact animals undergoing behavioral condition-
ing, or (2) the fact that current versions of in vitro EU-conditioning 
(using isolated nervous systems) are low-yield experiments, requir-
ing at least 10 unpaired conditioning trials delivered over a lengthy 
interval (∼100 min) in order to observe EU-specific changes (J. Farley, 
unpublished observations). Although difficult to test at present, based 
on our current results, we would expect that specific 12-lipoxygenase 
inhibitors such as baicalein applied prior to and during EU condition-
ing might substantially prevent the reduction in spiking and increases 
in I
A
 that are otherwise observed.
aa’s effects on voltage-dependent k+ channels In B cells
In initial voltage-clamp experiments, AA was found to increase the 
rapid, transient component of voltage-dependent K+ current in B 
cells, I
A
. A small, but more variable and non-significant, enhance-
ment of I
Delayed
 was also observed. Comparisons of AA’s effects on 
K+ currents from untrained animals with the effects of behavioral 
EU conditioning are revealing. Behavioral EU training significantly 
increases both I
A
 and I
Delayed
 (Farley et al., 1999) and enhancement 
of I
Delayed
 is largely due to enhancement of I
K(Ca)
. The enhancement 
of I
A
 by both AA and EU conditioning is particularly interesting, 
since this current is active in the subthreshold range of membrane 
potentials in B cells (Blackwell, 2006; Jin et al., 2009), and is a major 
determinant of spike frequency in many cells, including B cells.
This may provide a (partial) explanation for why AA, 12(S)-
HPETE, and 12-lipoxygenase inhibitors all failed to affect the SSGP 
of B cells, while behavioral EU conditioning produces a clear and 
strong reduction. Our previous empirical results (Farley, 1988; Jin 
et al., 2009) indicate that combined changes in I
A
 and I
K(Ca)
 are 
required to substantially affect the SSGP in a manner that mimics 
the effects of paired (excitatory) behavioral training. Large changes 
in I
A
 alone produce relatively small (∼2 mV) changes in SSGP. By 
analogy, perhaps EU-training produced increases in both I
A
 and 
I
Delayed
 (I
K–Ca
) are required to significantly reduce the SSGP response, 
while increases in I
A 
alone may be sufficient to significantly reduce 
spiking. This dissociation between control of spiking and the SSGP 
is further supported by SSGP data for B cells from untrained, EU0, 
and EU24 animals. While the light-evoked spike frequency in B 
cells from EU0 animals was not significantly different from the 
untrained or EU24 conditions, the SSGP for B cells from EU0 ani-
mals was significantly different from that of untrained animals.
Thus, AA metabolism pathways may affect only one of the 
principal K+ currents affected by EU conditioning. Our present 
results obviously represent just an initial step in characterizing the 
effects of AA-signaling upon ionic conductance systems in Type 
B photoreceptors. Clearly, we also need to examine the effects of 
12(S)-HPETE upon the K+ currents, and to also assess the effects 
of both AA and 12(S)-HPETE upon other ionic currents in B cells. 
We think it unlikely that AA-signaling is the only pathway to play 
a role in EU conditioning; the failure of AA and 12(S)-HPETE to 
affect the SSGP response underscores this point.
InvolveMent of aa and lIpoxygenase MetaBolItes In 
eu-condItIonIng
Two observations implicate AA- and lipoxygenase-signaling in EU 
conditioning. First, when tested shortly after the conclusion of EU 
conditioning, AA failed to reduce spiking in B cells from EU0 ani-
mals, an apparent occlusion effect. One anomalous result which we 
do not understand concerns the spiking rates of B cells from EU0 ani-
mals, measured prior to AA application, which was not significantly 
less than that of untrained control cells (∼6–7 Hz) (Figure 6B). If, 
during the course of EU-conditioning, 12-lipoxygenase activity had 
metabolized AA such that lipoxygenase metabolites were present 
and active shortly following training (thereby accounting for the 
occlusion effect), we would have expected the spike rates of B cells to 
be closer to that of EU24 animals (i.e., reduced relative to controls). 
Two possible explanations of this inconsistency are: (1) transient 
activation of an opposing signaling pathway by EU-conditioning 
stimulated AA metabolism, or another pathway, that increases 
excitability and spiking of B cells and masks the decreases pro-
duced by 12-lipoxygenase metabolites. One such candidate path-
way is PKC. (2) A downregulation/desensitization/inhibition of 
AA-metabolic pathways because of prolonged stimulation during 
the lengthy EU-conditioning sessions (∼4.5–5 h), perhaps because 
of feedback inhibition from lipoxygenase metabolites, depletion of 
AA, and/or the redox state of 12-lipoxygenase (which strongly influ-
ences its activity) that might be influenced by conditioning. The 
conspicuous larger-than-normal variability in the spike rates for 
B cells from EU0 animals (Figure 5B) vs. those of either untrained 
or EU24 animals suggests a possible corresponding increase in the 
number of distinct signaling pathways that are active shortly after 
EU conditioning in EU0 animals.
A second result that supports the involvement of 12-lipoxygen-
ase signaling during EU conditioning was the finding that baicalein 
reversed the EU-produced reductions in spiking of B cells from 
EU24 animals (measured prior to AA-application). This suggests 
that activity somewhere along the 12-lipoxgenase signaling pathway 
may be enhanced 24 h following training, such that constitutively 
produced 12(S)-HPETE is responsible for ongoing depression of 
spiking. According to this view, blocking 12-lipoxygenase activity 
might rapidly reduce the basal concentration of 12-lipoxygenase 
metabolites in B cells of previously conditioned EU24 animals, to 
levels not very different from untrained controls. However, if B 
cells (in the absence of baicalein) from EU24 animals have elevated 
12(S)-HPETE levels, it is not obvious why they showed as strong a 
response to AA as untrained controls. One might instead expect an 
occlusion effect. However, if upregulation is occurring within the 
12-lipoxygenase signaling pathway by EU conditioning, the result 
may not be entirely surprising. Upregulation of 12-lipoxygenase 
activity (e.g., increases in either the amount of 12-lipoxygenase 
expressed, or the V
max 
or K
M 
of the enzyme) might occur as a result 
of EU-conditioning, with the result that AA metabolism to 12- 
lipoxygenase metabolites is enhanced relative to untrained cells.
With the exception of the preceding results for baicalein on cells 
from EU24 animals, which are plausibly viewed as a test for the involve-
ment of 12-lipoxygenase metabolites upon maintained expression of 
the reduction in spiking that is produced by EU conditioning, we have 
not yet tested for the involvement of AA/lipoxygenase metabolism 
in the induction of EU-conditioning produced alterations in B cells. 
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of inhibitory conditioning share common cellular and molecu-
lar mechanisms. At the moment, there is little apparent overlap. 
Our studies raise the provocative possibilities that AA-signaling 
may participate in both excitatory and inhibitory classical 
conditioning in Hermissenda, with the former occurring via 
direct binding and synergistic activation of PKC, and the latter 
occurring through AA-metabolism by 12-lipoxygenase. Our 
results suggest that similar to behavioral EU-conditioning, 
AA-signaling increases I
A
 and thereby decreases light-evoked 
spiking in B cells. Because I
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 is decreased by pairings of light 
and rotation (Alkon et al., 1985; Farley, 1988) and contributes 
to the increased spiking of B cells from animals that have under-
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potentIal Model for the InvolveMent of aa In excItatory and 
InhIBItory condItIonIng
While we present evidence in this paper that AA indirectly mediates 
the reduction in spike frequency produced by EU training, AA has also 
been reported to act synergistically with diacylglycerol (DAG) and Ca2+ 
to activate PKC in B cells (Lester et al., 1991), suggesting its involvement 
in excitatory conditioning (Talk et al., 1997; Muzzio et al., 2001).This 
potential dual role for AA signaling can be accommodated by several 
models. A simple one that we favor involves differential binding of AA 
with PKC vs. metabolism of AA by the 12-lipoxygenase enzyme. In this 
model, when AA is released in the presence of PKC activating-cofactors 
(DAG and Ca2+), AA facilitates activation of PKC and excitatory condi-
tioning changes (reductions in K+ currents, enhanced light response, 
and spiking). In contrast, when AA is released in the absence of PKC 
activating-cofactors, metabolism of AA by a 12-lipoxygenase enzyme 
dominates, and some of the inhibitory conditioning changes occur 
(increases in I
A
 and decreased light-evoked spiking). Furthermore, 
if AA is bound to PKC, this may preclude metabolism of AA by a 
12-lipoxygenase enzyme. Alternatively, activation of PKC may block 
12-lipoxygenase signaling. Although AA signaling may be common 
to both excitatory and inhibitory conditioning in Hermissenda, direct 
binding of AA to PKC may be an important process for excitatory 
conditioning, while 12-lipoxygenase metabolism of AA may be an 
important process for inhibitory conditioning.
suMMary
The results of the present study are the first to demonstrate 
a signaling pathway (AA-lipoxygenase metabolism) that is 
implicated in conditioned inhibitory learning for any species. 
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